Income Statement DaVita Inc.

Equities

DVA

US23918K1088

Healthcare Facilities & Services

Market Closed - Nyse Other stock markets 16:00:02 2026-03-11 EDT			5-day change	1st Jan Change
154.81 ^USD	+2.15%		+0.01%	+36.26%

03-02	DaVita Inc. Presents at TD Cowen 46th Annual Health Care Conference, Mar-02-2026 11:50 AM
02-13	Three hurt working on Exxon Beaumont, Texas small CDU, sources say	RE

ddbba137cf3fda7acb3cfdbea.WOUcMMuN0e8E4oRLDT70kCXDFvEk21eCXEY2gn2NCVg.KJB6XZPK4KQyl8Yee2u26k-5JrlTlB_qNwpn6TG-Sxs1j1NEqbu0uGm77w

Published financial data: DAVITA INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	11.21B	11.18B	11.57B	12.26B	13.01B
Other Revenues, Total	405M	433M	565M	555M	636M
Total Revenues	11.62B	11.61B	12.14B	12.82B	13.64B
Cost of Goods Sold, Total	7.97B	8.21B	8.32B	8.6B	9.24B
Gross Profit	3.65B	3.4B	3.82B	4.22B	4.4B
Selling General & Admin Expenses, Total	1.2B	1.36B	1.47B	1.54B	1.65B
Depreciation & Amortization - (IS)	681M	733M	745M	724M	715M
Other Operating Expenses, Total	1.88B	2.09B	2.22B	2.26B	2.36B
Operating Income	1.77B	1.31B	1.6B	1.95B	2.04B
Interest Expense, Total	-280M	-369M	-502M	-529M	-570M
Interest And Investment Income	-	-	-	-	-
Net Interest Expenses	-280M	-369M	-502M	-529M	-570M
Income (Loss) On Equity Invest.	26.94M	26.52M	27.86M	26.19M	33M
Other Non Operating Income (Expenses)	4.64M	16.12M	84.39M	101M	13.94M
EBT, Excl. Unusual Items	1.52B	986M	1.21B	1.55B	1.51B
Restructuring Charges	-	-	-	-	-
Merger & Related Restructuring Charges	-	-	-	-	-
Impairment of Goodwill	-	-	-26.08M	-	-
Gain (Loss) On Sale Of Investments	-3.77M	-20.15M	-	-113M	-139M
Gain (Loss) On Sale Of Assets	-	-	-	109M	-
Asset Writedown	-	-	-	-	-
Legal Settlements	-	-	-	-	-
Other Unusual Items	-	-	-7.96M	-19.81M	-26.78M
EBT, Incl. Unusual Items	1.52B	966M	1.18B	1.53B	1.35B
Income Tax Expense	307M	198M	220M	280M	293M
Earnings From Continuing Operations	1.21B	768M	957M	1.25B	1.05B
Earnings Of Discontinued Operations	-	13.45M	-	-	25M
Net Income to Company	1.21B	782M	957M	1.25B	1.08B
Minority Interest	-233M	-221M	-265M	-314M	-332M
Net Income - (IS)	978M	560M	692M	936M	747M
Net Income to Common Incl Extra Items	978M	560M	692M	936M	747M
Net Income to Common Excl. Extra Items	978M	547M	692M	936M	722M
Per Share Items
Net EPS - Basic	9.3	6.03	7.62	11.02	10.06
Basic EPS - Continuing Operations	9.3	5.88	7.62	11.02	9.72
Basic Weighted Average Shares Outstanding	105M	92.99M	90.79M	84.99M	74.23M
Net EPS - Diluted	8.9	5.85	7.42	10.73	9.84
Diluted EPS - Continuing Operations	8.9	5.71	7.42	10.73	9.51
Diluted Weighted Average Shares Outstanding	110M	95.83M	93.18M	87.27M	75.88M
Normalized Basic EPS	6.82	4.25	5.41	7.72	8.27
Normalized Diluted EPS	6.53	4.12	5.27	7.52	8.09
American Depositary Receipts Ratio (ADR)	1	1	1	1	1
Supplemental Items
EBITDA	2.45B	2.05B	2.35B	2.68B	2.75B
EBITA	1.78B	1.32B	1.61B	1.96B	2.04B
EBIT	1.77B	1.31B	1.6B	1.95B	2.04B
EBITDAR	3.12B	2.72B	3.04B	3.37B	3.45B
Total Revenues (As Reported)	11.62B	11.61B	12.14B	12.82B	13.64B
Effective Tax Rate - (Ratio)	20.2	20.5	18.7	18.27	21.76
Current Domestic Taxes	232M	190M	238M	306M	161M
Current Foreign Taxes	14.25M	16.25M	21.01M	31.53M	45.34M
Total Current Taxes	246M	206M	259M	337M	207M
Deferred Domestic Taxes	64.87M	-10.81M	-39.87M	-50.57M	87.73M
Deferred Foreign Taxes	-4.52M	3M	535K	-7.22M	-1.16M
Total Deferred Taxes	60.34M	-7.81M	-39.33M	-57.79M	86.57M
Normalized Net Income	718M	395M	492M	657M	614M
Interest Capitalized	15.28M	12.68M	9.18M	7.98M	-
Interest on Long-Term Debt	29.26M	25.45M	20.9M	18.86M	8.98M
Supplemental Operating Expense Items
General and Administrative Expenses	1.2B	1.36B	1.47B	1.54B	1.65B
Net Rental Expense, Total	674M	680M	693M	689M	702M
Imputed Operating Lease Interest Expense	137M	174M	247M	255M	257M
Imputed Operating Lease Depreciation	537M	505M	446M	434M	445M
Stock-Based Comp., Other (Total)	102M	95.43M	112M	103M	140M
Total Stock-Based Compensation	102M	95.43M	112M	103M	140M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	462M	244M	380M	795M	676M
Short Term Investments	22.31M	77.69M	11.61M	51.06M	24.3M
Total Cash And Short Term Investments	484M	322M	392M	846M	701M
Accounts Receivable, Total	1.96B	2.13B	2.22B	2.4B	2.69B
Other Receivables	453M	419M	194M	160M	273M
Total Receivables	2.41B	2.55B	2.42B	2.56B	2.96B
Inventory	107M	109M	143M	135M	161M
Prepaid Expenses	72.52M	78.84M	103M	123M	156M
Restricted Cash	93.06M	94.9M	84.57M	84.89M	81.31M
Other Current Assets, Total	-	-	-	-	-
Total Current Assets	3.17B	3.16B	3.14B	3.75B	4.06B
Gross Property Plant And Equipment	11.07B	11.19B	11.33B	11.6B	11.81B
Accumulated Depreciation	-4.76B	-5.27B	-5.76B	-6.26B	-6.6B
Net Property Plant And Equipment	6.3B	5.92B	5.57B	5.33B	5.21B
Long-term Investments	301M	415M	674M	400M	210M
Goodwill	7.05B	7.08B	7.11B	7.38B	7.55B
Other Intangibles, Total	178M	183M	203M	197M	222M
Deferred Tax Assets Long-Term	22.91M	27.71M	34.44M	46.25M	69.74M
Other Long-Term Assets, Total	102M	148M	157M	185M	165M
Total Assets	17.12B	16.93B	16.89B	17.29B	17.48B
Liabilities
Accounts Payable, Total	402M	480M	515M	547M	696M
Accrued Expenses, Total	790M	838M	910M	1B	1.04B
Current Portion of Long-Term Debt	142M	194M	86.13M	234M	74.58M
Current Portion of Leases	431M	433M	432M	447M	460M
Current Income Taxes Payable	53.79M	18.04M	28.51M	10.3M	24.36M
Other Current Liabilities	579M	657M	671M	732M	842M
Total Current Liabilities	2.4B	2.62B	2.64B	2.97B	3.14B
Long-Term Debt	8.47B	8.46B	8.05B	9B	10.01B
Long-Term Leases	2.93B	2.74B	2.55B	2.39B	2.33B
Deferred Tax Liability Non Current	831M	783M	726M	665M	757M
Other Non Current Liabilities	119M	105M	183M	170M	83.52M
Total Liabilities	14.75B	14.7B	14.15B	15.19B	16.32B
Common Stock, Total	97K	90K	89K	90K	69K
Additional Paid In Capital	540M	607M	510M	286M	-
Retained Earnings	354M	174M	598M	1.53B	-328M
Treasury Stock	-	-	-	-1.39B	-200M
Comprehensive Income and Other	-139M	-69.19M	-52.08M	-311M	-123M
Total Common Equity	756M	712M	1.06B	121M	-651M
Minority Interest	1.62B	1.51B	1.69B	1.97B	1.81B
Total Equity	2.37B	2.22B	2.74B	2.09B	1.16B
Total Liabilities And Equity	17.12B	16.93B	16.89B	17.29B	17.48B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	96.3M	90.4M	87.7M	80M	66.8M
ECS Total Common Shares Outstanding	97.29M	90.41M	88.82M	80.54M	68.55M
Book Value / Share	7.77	7.88	11.89	1.5	-9.5
Tangible Book Value	-6.47B	-6.55B	-6.26B	-7.45B	-8.42B
Tangible Book Value Per Share	-66.49	-72.41	-70.47	-92.52	-122.81
Total Debt	11.98B	11.82B	11.12B	12.07B	12.87B
Net Debt	11.49B	11.5B	10.72B	11.22B	12.17B
Debt Equivalent Oper. Leases	5.39B	5.44B	5.54B	5.51B	5.62B
Minority Interest, Total (Incl. Fin. Div)	1.62B	1.51B	1.69B	1.97B	1.81B
Equity Method Investments, Total	224M	216M	531M	315M	133M
Account Code - Inventory Valuation	5	5	5	5	5
Land - (BS)	34.01M	32.66M	35.22M	50.17M	40.5M
Buildings, Total	496M	428M	436M	429M	403M
Machinery, Total	3.29B	3.76B	4.13B	4.41B	4.54B
Full Time Employees	69K	70K	70K	76K	78K
Accumulated Allowance for Doubtful Accounts (Supple)	-	-	-	-	-

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	978M	560M	692M	936M	747M
Depreciation & Amortization - CF	668M	721M	736M	716M	708M
Amortization of Goodwill and Intangible Assets - (CF)	12.86M	11.47M	8.97M	7.46M	7.1M
Depreciation & Amortization, Total	681M	733M	745M	724M	715M
(Gain) Loss From Sale Of Asset	-	-	-	-	-17.55M
(Gain) Loss on Sale of Investments - (CF)	-	-	-	-109M	-
Asset Writedown & Restructuring Costs	-	-	26.08M	-	-
(Income) Loss On Equity Investments - (CF)	5.22M	8.77M	64.78M	116M	134M
Stock-Based Compensation (CF)	102M	95.43M	112M	103M	140M
Tax Benefit from Stock Options	-	-	-	-	-
Net Cash From Discontinued Operations	-	-	-	-	-
Other Operating Activities, Total	305M	167M	224M	282M	431M
Change In Accounts Receivable	-138M	-148M	172M	-29.77M	-211M
Change In Inventories	5.72M	-757K	-32.13M	17.94M	-19.95M
Change In Accounts Payable	-30.32M	87.48M	26.89M	1.7M	128M
Change In Income Taxes	36.92M	-24.1M	1.57M	-44.21M	50.24M
Change in Other Net Operating Assets	-14.82M	85.87M	25.85M	24.52M	-211M
Cash from Operations	1.93B	1.56B	2.06B	2.02B	1.89B
Capital Expenditure	-641M	-603M	-568M	-555M	-576M
Sale of Property, Plant, and Equipment	61.46M	118M	30.61M	25.86M	34.17M
Cash Acquisitions	-187M	-57.31M	-26.39M	-246M	-117M
Investment in Marketable and Equity Securities, Total	-16.94M	-86.41M	-208M	4.22M	4.21M
Other Investing Activities, Total	-745K	-782K	-	-	-
Cash from Investing	-785M	-630M	-772M	-771M	-655M
Long-Term Debt Issued, Total	1.62B	2.39B	2.47B	6.62B	5.61B
Total Debt Issued	1.62B	2.39B	2.47B	6.62B	5.61B
Long-Term Debt Repaid, Total	-861M	-2.4B	-3.02B	-5.52B	-4.79B
Total Debt Repaid	-861M	-2.4B	-3.02B	-5.52B	-4.79B
Issuance of Common Stock	-	-	-	20.45M	23.29M
Repurchase of Common Stock	-1.6B	-840M	-320M	-1.52B	-1.83B
Other Financing Activities, Total	-239M	-270M	-298M	-427M	-393M
Cash from Financing	-1.08B	-1.12B	-1.17B	-817M	-1.37B
Foreign Exchange Rate Adjustments	-10.01M	-29.07M	8.91M	-18.48M	21.15M
Net Change in Cash	53.17M	-216M	126M	415M	-122M
Supplemental Items
Cash Interest Paid	279M	351M	388M	-	-
Cash Income Tax Paid (Refund)	210M	344M	268M	388M	177M
Levered Free Cash Flow	1.08B	832M	1.2B	1.18B	1.05B
Unlevered Free Cash Flow	1.26B	1.06B	1.51B	1.51B	1.41B
Change In Net Working Capital	-7.19M	-17.8M	-219M	-13.77M	142M
Net Debt Issued / Repaid	754M	-11.28M	-553M	1.11B	823M

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	6.49	4.82	5.92	7.15	7.32
Return on Total Capital	7.78	5.78	7.17	8.72	9.03
Return On Equity %	46.01	33.43	38.52	51.74	64.85
Return on Common Equity	91.48	74.52	78.21	159.08	-272.4
Margin Analysis
Gross Profit Margin %	31.38	29.29	31.47	32.91	32.26
SG&A Margin	10.29	11.67	12.14	12	12.09
EBITDA Margin %	21.1	17.62	19.33	20.9	20.17
EBITA Margin %	15.35	11.4	13.26	15.31	14.97
EBIT Margin %	15.24	11.31	13.19	15.25	14.92
Income From Continuing Operations Margin %	10.43	6.62	7.88	9.76	7.72
Net Income Margin %	8.42	4.83	5.7	7.31	5.47
Net Avail. For Common Margin %	8.42	4.71	5.7	7.31	5.29
Normalized Net Income Margin	6.18	3.4	4.05	5.12	4.5
Levered Free Cash Flow Margin	9.3	7.17	9.85	9.18	7.72
Unlevered Free Cash Flow Margin	10.8	9.15	12.43	11.76	10.33
Asset Turnover
Asset Turnover	0.68	0.68	0.72	0.75	0.78
Fixed Assets Turnover	1.83	1.9	2.11	2.35	2.59
Receivables Turnover (Average Receivables)	5.93	5.47	5.17	5.31	5.12
Inventory Turnover (Average Inventory)	72.79	75.82	65.97	61.93	62.62
Short Term Liquidity
Current Ratio	1.32	1.2	1.19	1.26	1.29
Quick Ratio	1.21	1.1	1.06	1.14	1.16
Operating Cash Flow to Current Liabilities	0.81	0.6	0.78	0.68	0.6
Days Sales Outstanding (Average Receivables)	61.55	66.78	70.61	68.96	71.34
Days Outstanding Inventory (Average Inventory)	5.01	4.81	5.53	5.91	5.83
Average Days Payable Outstanding	19.15	19.6	21.72	22.62	24.48
Cash Conversion Cycle (Average Days)	47.41	51.99	54.42	52.25	52.69
Long Term Solvency
Total Debt/Equity	505.08	531.4	405.21	576.99	1.11K
Total Debt / Total Capital	83.47	84.16	80.21	85.23	91.74
LT Debt/Equity	480.89	503.22	386.34	544.41	1.07K
Long-Term Debt / Total Capital	79.48	79.7	76.47	80.42	87.93
Total Liabilities / Total Assets	86.15	86.86	83.76	87.9	93.37
EBIT / Interest Expense	6.33	3.56	3.19	3.7	3.57
EBITDA / Interest Expense	11.17	7.39	6.05	6.37	6.06
(EBITDA - Capex) / Interest Expense	8.88	5.75	4.92	5.32	5.05
Total Debt / EBITDA	3.83	4.34	3.66	3.58	3.73
Net Debt / EBITDA	3.68	4.22	3.53	3.33	3.53
Total Debt / (EBITDA - Capex)	4.82	5.57	4.5	4.29	4.47
Net Debt / (EBITDA - Capex)	4.63	5.42	4.34	3.99	4.23
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	0.59	-0.08	4.57	5.56	6.46
Gross Profit, 1 Yr. Growth %	2.37	-6.75	12.35	10.38	4.35
EBITDA, 1 Yr. Growth %	4.33	-16.56	14.73	14.16	2.71
EBITA, 1 Yr. Growth %	2.92	-25.75	21.6	21.88	4.11
EBIT, 1 Yr. Growth %	2.99	-25.86	21.98	22.1	4.14
Earnings From Cont. Operations, 1 Yr. Growth %	20.65	-36.61	24.58	30.7	-15.75
Net Income, 1 Yr. Growth %	26.47	-42.73	23.4	35.4	-20.24
Normalized Net Income, 1 Yr. Growth %	4.35	-44.77	24.35	24.17	-6.54
Diluted EPS Before Extra, 1 Yr. Growth %	39.28	-35.84	29.95	44.61	-11.37
Accounts Receivable, 1 Yr. Growth %	7.31	8.91	-1.55	7.94	12.03
Inventory, 1 Yr. Growth %	-3.76	1.58	31.14	-5.97	19.37
Net Property, Plant and Equip., 1 Yr. Growth %	-1.26	-6.06	-5.87	-4.31	-2.33
Total Assets, 1 Yr. Growth %	0.78	-1.13	-0.2	2.32	1.13
Tangible Book Value, 1 Yr. Growth %	13.44	1.21	-4.39	19.04	12.97
Common Equity, 1 Yr. Growth %	-45.39	-5.72	48.26	-88.53	-637.54
Cash From Operations, 1 Yr. Growth %	-2.43	-18.97	31.6	-1.8	-6.7
Capital Expenditures, 1 Yr. Growth %	-4.9	-5.93	-5.87	-2.21	3.68
Levered Free Cash Flow, 1 Yr. Growth %	44.17	-22.96	43.64	-1.6	-10.47
Unlevered Free Cash Flow, 1 Yr. Growth %	34.25	-15.32	42.02	-0.17	-6.46
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	1.01	0.26	2.22	5.06	6.01
Gross Profit, 2 Yr. CAGR %	2.45	-2.3	2.36	11.36	7.32
EBITDA, 2 Yr. CAGR %	1.68	-6	-2.16	14.45	8.28
EBITA, 2 Yr. CAGR %	0.38	-11.69	-4.98	21.74	12.65
EBIT, 2 Yr. CAGR %	0.42	-11.71	-4.91	22.04	12.76
Earnings From Cont. Operations, 2 Yr. CAGR %	15.03	-12.54	-11.13	27.6	4.93
Net Income, 2 Yr. CAGR %	9.84	-14.89	-15.93	29.26	3.92
Normalized Net Income, 2 Yr. CAGR %	6.28	-23.11	-17.13	28.4	7.73
Diluted EPS Before Extra, 2 Yr. CAGR %	39.34	-5.47	-8.69	37.08	13.21
Accounts Receivable, 2 Yr. CAGR %	4.41	8.11	6.53	3.08	9.96
Inventory, 2 Yr. CAGR %	4.73	-1.13	15.42	11.05	5.95
Net Property, Plant and Equip., 2 Yr. CAGR %	0.01	-3.69	-5.97	-5.1	-3.33
Total Assets, 2 Yr. CAGR %	-0.55	-0.18	-0.67	1.05	1.72
Tangible Book Value, 2 Yr. CAGR %	16.21	7.15	-1.63	6.68	15.97
Common Equity, 2 Yr. CAGR %	-40.49	-28.25	18.23	-58.76	-21.48
Cash From Operations, 2 Yr. CAGR %	-12.05	-11.09	3.27	13.68	-4.28
Capital Expenditures, 2 Yr. CAGR %	-8.52	-5.42	-5.9	-4.06	0.69
Levered Free Cash Flow, 2 Yr. CAGR %	-54.42	6.97	5.2	18.89	-6.14
Unlevered Free Cash Flow, 2 Yr. CAGR %	-52.11	7.89	9.66	19.07	-3.36
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	0.6	0.64	1.67	3.32	5.53
Gross Profit, 3 Yr. CAGR %	4.27	-0.71	2.36	4.97	8.98
EBITDA, 3 Yr. CAGR %	5.6	-4.8	0.46	3	10.39
EBITA, 3 Yr. CAGR %	5.79	-9.22	-1.75	3.24	15.55
EBIT, 3 Yr. CAGR %	5.91	-9.24	-1.67	3.36	15.76
Earnings From Cont. Operations, 3 Yr. CAGR %	15.32	-5.69	-1.6	1.06	11.11
Net Income, 3 Yr. CAGR %	83.1	-11.59	-3.67	-1.46	10.04
Normalized Net Income, 3 Yr. CAGR %	16.3	-14.65	-9.75	-2.84	15.5
Diluted EPS Before Extra, 3 Yr. CAGR %	35.57	7.59	5.11	6.43	18.54
Accounts Receivable, 3 Yr. CAGR %	1.74	5.89	6.79	7	5.98
Inventory, 3 Yr. CAGR %	0.01	3.67	8.63	7.79	13.75
Net Property, Plant and Equip., 3 Yr. CAGR %	22.93	-2.06	-4.42	-5.42	-4.18
Total Assets, 3 Yr. CAGR %	-3.6	-0.74	-0.19	0.32	1.08
Tangible Book Value, 3 Yr. CAGR %	25.69	10.98	3.16	4.83	8.74
Common Equity, 3 Yr. CAGR %	-41.13	-30.63	-8.61	-45.68	-2.95
Cash From Operations, 3 Yr. CAGR %	8.05	-14.42	1.33	1.55	6.44
Capital Expenditures, 3 Yr. CAGR %	-13.38	-7.67	-5.57	-4.69	-1.55
Levered Free Cash Flow, 3 Yr. CAGR %	28.14	-45.7	18.01	2.88	8.16
Unlevered Free Cash Flow, 3 Yr. CAGR %	15.59	-42.09	18.24	6.28	9.87
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	1.67	1.3	1.24	2.39	3.39
Gross Profit, 5 Yr. CAGR %	2.24	0.95	3.5	3.95	4.32
EBITDA, 5 Yr. CAGR %	0.27	-3.22	2.43	2.47	3.52
EBITA, 5 Yr. CAGR %	0.82	-4.27	1.34	2.09	3.77
EBIT, 5 Yr. CAGR %	0.84	-4.26	1.45	2.17	3.87
Earnings From Cont. Operations, 5 Yr. CAGR %	0.34	-6.52	3.91	6.43	0.96
Net Income, 5 Yr. CAGR %	2.15	-3.32	34.11	2.92	-0.7
Normalized Net Income, 5 Yr. CAGR %	1.58	-7.67	1.49	0.64	-1.7
Diluted EPS Before Extra, 5 Yr. CAGR %	11.95	3.74	15.75	18.54	8.28
Accounts Receivable, 5 Yr. CAGR %	5.41	4.45	3.63	5.96	8.05
Inventory, 5 Yr. CAGR %	-7.71	-9.7	5.91	6.56	7.55
Net Property, Plant and Equip., 5 Yr. CAGR %	17.09	13.47	10.44	-3.28	-3.98
Total Assets, 5 Yr. CAGR %	-1.81	-2.26	-2.44	-0.03	0.57
Tangible Book Value, 5 Yr. CAGR %	35.03	26.34	13.96	9.24	8.1
Common Equity, 5 Yr. CAGR %	-30.47	-31.4	-22.19	-43.66	-13.99
Cash From Operations, 5 Yr. CAGR %	-0.58	-4.47	6.11	-4.13	-0.95
Capital Expenditures, 5 Yr. CAGR %	-5	-7.79	-10.47	-6.24	-3.11
Levered Free Cash Flow, 5 Yr. CAGR %	-25.33	-4.3	18.42	-25.71	7.68
Unlevered Free Cash Flow, 5 Yr. CAGR %	-22.18	-3.97	13.18	-22.73	9.07